MarginsXMarginsX
Home › Markets › Health Care › IRTC

iRhythm Holdings Inc. (IRTC)

IRTC trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$90.83
-1.18% on the day
Market cap
$3.1B
Mid cap
Revenue · 2025
$747.1M
+26.2% on 2024
Net income · 2025
-$44.6M
-6.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1388658/000138865826000011/0001388658-26-000011-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerIRTC on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2016
SEC CIK0001388658
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDELAWARE

Financials · 2025

LineValue
Revenue$747.1M
Net income-$44.6M
Operating income-$57.4M
Net margin-6.0%
Operating margin-7.7%
Revenue growth+26.2%
Cash$236.0M
Total assets$1.0B
P/E (computed)Net income was not positive
P/S (computed)4.1×

Warning signs

Cash runway
Cash-flow positive
$394.7M cash at September 30, 2026
Share count, 1 year
+4.3%
2025-10-23 to 2026-10-29 · +9.7% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$27.8M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$394.7M cash; operating cash flow $13.9M a quarter.Report 2026-09-30
Shares outstanding33,618,146 (2026-10-29); 32,219,143 a year earlier; 30,650,758 three years earlier.Cover page 2026-10-29
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, San Jose, California, United States; changed auditors 1 time in 24 months8-K 4.01 2026-04-01
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $57K, sold $27.9M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$221.6M-$29.9M$4.4M$394.7MNo debt tags$854.0M10-Q 2026-11-05
Q2 2026
2026-06-30
$224.2M-$381K$51.1M$246.7MNo debt tags$825.3M10-Q 2026-08-06
Q1 2026
2026-03-31
$199.4M-$13.9M-$26.2M$240.1MNo debt tags$787.9M10-Q 2026-04-30
Q4 2025
2025-12-31
$208.9M$5.6M$26.2M$236.0MNo debt tags$747.1M10-K 2026-02-19
Q3 2025
2025-09-30
$192.9M-$5.2M$34.9M$255.6MNo debt tags$702.6M10-Q 2026-11-05
Q2 2025
2025-06-30
$186.7M-$14.2M$27.7M$309.1MNo debt tags$657.2M10-Q 2026-08-06
Q1 2025
2025-03-31
$158.7M-$30.7M-$7.9M$375.3MNo debt tags$618.6M10-Q 2026-04-30
Q4 2024
2024-12-31
$164.3M-$1.3M$19.2M$419.6M$0$591.8M10-K 2026-02-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42020-08-19
Latest annual report10-K2026-02-19
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-13
Latest proxyDEFA14A2026-04-17

Source: SEC EDGAR submissions feed, 855 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.9%
1 month-14.7%
3 months-25.4%
Year to date-48.2%
1 year-45.5%
From 52-week high-51.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
VVVVvVARDIS Holding AG$16.00-3.03%$2.9B
ATRCAtriCure Inc.$55.31-2.69%$2.8B
PLSEPulse Biosciences Inc Common Stock (DE)$46.36-8.09%$3.4B
NVSTEnvista Holdings Corporation$24.03-1.88%$3.9B
UFPTUFP Technologies Inc.$298.54-2.14%$2.3B
HTFLHeartflow Inc.$46.86-3.30%$4.1B
STVNStevanato Group S.p.A.$15.53-1.71%$4.2B
ICUIICU Medical Inc.$181.87+1.45%$4.5B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier